Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Moderna (MRNA) posted Return on Capital Employed [ROCE] of -38.20% for Q2 2026, down 7.85 percentage points from -30.35% a year earlier and down 2.35 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Moderna's Return on Capital Employed [ROCE] came in at -27.32%, up 0.71 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +1000.83 percentage points (FY2020 to FY2025).
  • In prior years, Moderna's Return on Capital Employed [ROCE] was -28.02% in FY2024 (-5.86 pp), -22.16% in FY2023 (-68.47 pp), 46.31% in FY2022 (-147.08 pp) and 193.40% in FY2021 (+1221.55 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q4 2020.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -3.38 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 144.82 percentage points; the weakest was Q3 2023, with a drop of 85.23 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -35.85% (Q1 2026), -29.99% (Q4 2025) and -33.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 17.83%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 17.92%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 19.32%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 16.76%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -5.97%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 11.86%
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn -38.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.20%
Mar 31, 2026 -35.85%
Dec 31, 2025 -29.99%
Sep 30, 2025 -33.33%
Jun 30, 2025 -30.35%
Mar 31, 2025 -31.55%
Dec 31, 2024 -30.90%
Sep 30, 2024 -19.89%
Jun 30, 2024 -33.49%
Mar 31, 2024 -33.81%
Dec 31, 2023 -26.62%
Sep 30, 2023 -16.37%
Jun 30, 2023 2.58%
Mar 31, 2023 22.46%
Dec 31, 2022 44.78%
Sep 30, 2022 68.86%
Jun 30, 2022 78.16%
Mar 31, 2022 96.19%
Dec 31, 2021 97.28%
Sep 30, 2021 88.70%
API Access

Moderna Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY